Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017 (2017), Article ID 2470950, 8 pages
https://doi.org/10.1155/2017/2470950
Research Article

Neutral Sphingomyelinase Behaviour in Hippocampus Neuroinflammation of MPTP-Induced Mouse Model of Parkinson’s Disease and in Embryonic Hippocampal Cells

1Department of Pharmaceutical Science, University of Perugia, Perugia, Italy
2Department of Experimental Medicine, University of Perugia, Polo Unico Sant’Andrea delle Fratte, Piazzale Gambuli, 06132 Perugia, Italy
3Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelleépinière (ICM), 75013 Paris, France
4Department of Biology and Interdepartmental Research Center Nutrafood “Nutraceuticals and Food for Health”, University of Pisa, Pisa, Italy
5CRABiON-Perugia, Via Ponchielli 4, 06073 Perugia, Italy
6Department of Chemistry, Biology and Biotechnology, Via Elce di sotto, 06123 Perugia, Italy
7Dipartimento di Area Medica (DAME), University of Udine, P.le M. Kolbe 4, 33100 Udine, Italy

Correspondence should be addressed to Elisabetta Albi; ti.gpinu@ibla.attebasile

Received 24 May 2017; Revised 16 September 2017; Accepted 26 September 2017; Published 16 November 2017

Academic Editor: Vinod K. Mishra

Copyright © 2017 Samuela Cataldi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. McKenzie, L. J. Spielman, C. B. Pointer et al., “Neuroinflammation as a common mechanism associated with the modifiable risk factors for Alzheimer’s and Parkinson’s diseases,” Current Aging Science, vol. 10, no. 3, 2017. View at Publisher · View at Google Scholar
  2. S. Cataldi, M. Codini, S. Hunot et al., “e-cadherin in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson disease,” Mediators of Inflammation, vol. 2016, Article ID 3937057, 7 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. G. D. Manocha, A. M. Floden, K. L. Puig, K. Nagamoto-Combs, C. R. Scherzer, and C. K. Combs, “Defining the contribution of neuroinflammation to Parkinson’s disease in humanized immune system mice,” Molecular Neurodegeneration, vol. 12, no. 1, p. 17, 2017. View at Publisher · View at Google Scholar
  4. J. Castro-Hernández, P. A. Adlard, and D. I. Finkelstein, “Pramipexole restores depressed transmission in the ventral hippocampus following MPTP-lesion,” Scientific Reports, vol. 7, article 44426, 2017. View at Publisher · View at Google Scholar
  5. C. B. Schneider, M. Donix, K. Linse et al., “Accelerated age-dependent hippocampal volume loss in Parkinson disease with mild cognitive impairment,” American Journal of Alzheimers Disease & Other Dementias, vol. 32, no. 6, pp. 313–319, 2017. View at Publisher · View at Google Scholar
  6. I. J. Garcia, P. F. Kinoshita, C. Scavone, J. A. Mignaco, L. A. Barbosa, and L. Santos Hde, “Ouabain modulates the lipid composition of hippocampal plasma membranes from rats with LPS-induced neuroinflammation,” Journal of Membrane Biolology, vol. 248, no. 6, pp. 1191–1198, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Gualtierotti, L. Guarnaccia, M. Beretta et al., “Modulation of neuroinflammation in the central nervous system: role of chemokines and sphingolipids,” Advances in Therapy, vol. 34, no. 2, pp. 396–420, 2017. View at Publisher · View at Google Scholar
  8. A. Gulbins, H. Grassmé, R. Hoehn et al., “Regulation of neuronal stem cell proliferation in the hippocampus by endothelial ceramide,” Cellular Physiology and Biochemistry, vol. 39, no. 2, pp. 790–801, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. A. Hannun and L. M. Obeid, “Many ceramides,” Journal Biological Chemistry, vol. 286, pp. 27855–27862, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Gu, B. Huang, W. Shen et al., “Early activation of nSMase2/ceramide pathway in astrocytes is involved in ischemia-associated neuronal damage via inflammation in rat hippocampi,” Journal of Neuroinflammation, vol. 10, p. 109, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Singh and A. Chattopadhyay, “Removal of sphingomyelin headgroup inhibits the ligand binding function of hippocampal serotonin1A receptors,” Biochemical Biophys Research Communications, vol. 419, no. 2, pp. 321–325, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Dontigny, C. Patenaude, M. Cyr, and G. Massicotte, “Sphingomyelinase selectively reduces M1 muscarinic receptors in rat hippocampal membranes,” Hippocampus, vol. 22, no. 7, pp. 1589–1596, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Norman, R. G. Cutler, R. Flannery, Y. Wang, and M. P. Mattson, “Plasma membrane sphingomyelin hydrolysis increases hippocampal neuron excitability by a sphingosine-1-phosphate mediated mechanisms,” Journal of Neurochemistry, vol. 114, no. 2, pp. 430–439, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Y. Yoon, B. Danielson, D. Mathis, J. Karamchandani, and D. G. Munoz, “Cytomegalovirus in the human dentate gyrus and its impact on neural progenitor cells: report of two cases,” Clinical Neuropathology, vol. 36, pp. 240–245, 2017. View at Publisher · View at Google Scholar
  15. T. Okazaki, R. M. Bell, and Y. A. Hannun, “Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation,” Journal Biological Chemistry, vol. 264, no. 32, pp. 19076–19080, 1989. View at Google Scholar
  16. E. Bartoccini, F. Marini, E. Damaskopoulou et al., “Nuclear lipid microdomains regulate nuclear vitamin D3 uptake and influence embryonic hippocampal cell differentiation,” Molecular Biology of the Cell, vol. 22, no. 17, pp. 3022–3031, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Arcuri, I. Giambanco, R. Bianchi, and R. Donato, “Annexin V, annexin VI, S100A1 and S100B in developing and adult avian skeletal muscles,” Neuroscience, vol. 109, no. 2, pp. 371–388, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Albi, R. Lazzarini, and M. Viola Magni, “Phosphatidylcholine/sphingomyelin metabolism crosstalk inside the nucleus,” Biochemistry Journal, vol. 410, pp. 381–389, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Bienias, A. Fiedorowicz, A. Sadowska, S. Prokopiuk, and H. Car, “Regulation of sphingomyelin metabolism,” Pharmacological Reports, vol. 68, no. 3, pp. 570–581, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Chiasserini, E. Persichetti, S. Paciotti, T. Beccari, and L. Parnetti, “Lysosomal enzymes in PD: further evidence is needed,” Movement Disorders, vol. 29, no. 10, p. 1329, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Albi, A. Lazzarini, R. Lazzarini et al., “Nuclear lipid microdomain as place of interaction between sphingomyelin and DNA during liver regeneration,” International Journal Molecular Science, vol. 14, pp. 6529–6541, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Albi, S. Cataldi, G. Rossi et al., “The nuclear ceramide/diacylglycerol balance depends on the physiological state of thyroid cells and changes during UV-C radiation-induced apoptosis,” Archives Biochemistry Biophysics, vol. 478, no. 1, pp. 52–58, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Lazzarini, A. Floridi, L. Pugliese et al., “Analysis of serum sphingomyelin species by uflc-ms/ms in patients affected with monoclonal gammopathy,” Journal Chromatography Separation Techniques, vol. 5, article 1000239, 2014. View at Publisher · View at Google Scholar
  24. M. Garcia-Gil, A. Lazzarini, R. Lazzarini et al., “Serum deprivation alters lipid profile in HN9.10e embryonic hippocampal cells,” Neuroscience Letters, vol. 589, pp. 83–87, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Anusha, T. Sumathi, and L. D. Joseph, “Protective role of apigenin on rotenone induced rat model of Parkinson’s disease: suppression of neuroinflammation and oxidative stress mediated apoptosis,” Chemical-Biological Interactions, vol. 269, pp. 67–79, 2017. View at Publisher · View at Google Scholar
  26. M. Garcia-Gil and E. Albi, “Nuclear lipids in the nervous system: what they do in health and disease,” Neurochemical Research, vol. 42, no. 2, pp. 321–336, 2017. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Assi, D. Cazzato, C. De Palma, C. Perrotta, E. Clementi, and D. Cervia, “Sphingolipids and brain resident macrophages in neuroinflammation: an emerging aspect of nervous system pathology,” Clinical and Developmental Immunology, vol. 2013, Article ID 309302, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Yao, C. Cheung, S. Pang et al., “Multimodal MRI of the hippocampus in Parkinson’s disease with visual hallucinations,” Brain Structure and Function, vol. 221, no. 1, pp. 287–300, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Gu, B. Huang, W. Shen et al., “Early activation of nSMase2/ceramide pathway in astrocytes is involved in ischemia-associated neuronal damage via inflammation in rat hippocampi,” Journal of Neuroinflammation, vol. 3, no. 10, p. 109, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. N. A. Babenko and E. G. Shakhova, “Long-term food restriction prevents aging-associated sphingolipid turnover dysregulation in the brain,” Archives Gerontology Geriatrics, vol. 58, no. 3, pp. 420–426, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Lazzarini, A. Macchiarulo, A. Floridi et al., “Very-long-chain fatty acid sphingomyelin in nuclear lipid microdomains of hepatocytes and hepatoma cells: can the exchange from C24:0 to C16:0 affect signal proteins and vitamin D receptor?” Molecular Biology Cell, vol. 26, no. 13, pp. 2418–2425, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. F. Marini, E. Bartoccini, G. Cascianelli et al., “Effect of 1alpha,25-dihydroxyvitamin D3 in embryonic hippocampal cells,” Hippocampus, vol. 20, no. 6, pp. 696–705, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Manduca, A. Bara, T. Larrieu et al., “Amplification of mGlu5-endocannabinoid signaling rescues behavioral and synaptic deficits in a mouse model of adolescent and adult dietary, polyunsaturated fatty acid imbalance,” Journal of Neuroscience, vol. 37, no. 29, pp. 6851–6868, 2017. View at Publisher · View at Google Scholar
  34. A. L. Dinel, C. Rey, C. Bonhomme, P. Le Ruyet, C. Joffre, and S. Layé, “Dairy fat blend improves brain DHA and neuroplasticity and regulates corticosterone in mice,” Prostaglandins, Leukotrienes, and Essential Fatty Acids, vol. 109, pp. 29–38, 2016. View at Publisher · View at Google Scholar · View at Scopus